Schools get naloxone, feds get overdose data—a public health win
H.R. 7994 — HERO Act · Filed by Raul Ruiz (D-CA) · 1 cosponsor · Introduced Mar 19, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federal grant program to help schools purchase naloxone (opioid overdose reversal drugs) and develop emergency response plans and drug-prevention education. Schools receiving these grants must report to federal overdose-tracking systems whenever they distribute naloxone, and the HHS Secretary must report annually to Congress on grant usage and overdose responses.
Why we flagged it
The bill's operative mechanism is a competitive grant program to equip schools with naloxone and mandated overdose-response training. It is a straightforward public-health intervention with no hidden carve-outs or immunity provisions.
What the text implies
- Schools must report naloxone distribution to federal systems, creating a national database of overdose incidents in educational settings—potentially useful for epidemiology but also creating a permanent record tied to school locations and student populations.
- Grant awards are competitive and prioritize high-overdose areas, which may concentrate resources in certain regions while leaving lower-incidence areas without federal support.
The full analysis lists 4 implications of this text.
Who stands to gain
pharmaceutical manufacturers of naloxone (naloxone producers); schools and local educational agencies (grant recipients); emergency medical services and public health agencies (data recipients)